Rocket Pharmaceuticals

Rocket Pharmaceuticals

RCKT

Reported
Thursday, February 27

Q4 2024 Earnings

(USD)ExpectedReportedSurprise $Surprise %
EPS-0.72-0.620.1013.89%
Revenue31.3K0.00-31.3K-100.00%
WhatIF - Earnings
EPS Beat Expectations by $0.10
emptyImageAlt
Rocket Pharmaceuticals (RCKT:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything